CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $697,937
- in 4 filings, $698K under 10b5-1 plans
Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-07 | Hopkinson Craig C. SVP, Med Dev/Med Affairs, CMO | Exercise or conversion · Restricted Stock Unit Award | −1,250 | 3,750 | ||
| 2018-06-01 | MITCHELL PAUL J Director | Exercise or conversion | +1,000 | $8.98 | $9K | 1,000 |
| 2018-06-01 | MITCHELL PAUL J Director | Sale | −1,000 | $47.34 | $47K | 0 |
| 2018-06-01 | MITCHELL PAUL J Director | Exercise or conversion · Non Qualified Stock Option (Right to Buy) | −1,000 | 17,000 | ||
| 2018-05-24 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Exercise or conversion | +20,000 | $12.29 | $246K | 192,644 |
| 2018-05-24 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Sale | −20,000 | $45.22 | $904K | 172,644 |
| 2018-05-24 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Exercise or conversion · Employee Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2018-05-23 | Wysenski Nancy Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2018-05-23 | snyderman nancy lynn MD Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2018-05-23 | BLOOM FLOYD E Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2018-05-23 | DIXON WENDY L Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2018-05-23 | BREYER ROBERT A Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2018-05-23 | MITCHELL PAUL J Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2018-05-23 | Cooke Shane Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2018-05-23 | Cooke Shane Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +26,000 | 26,000 | ||
| 2018-05-23 | ANSTICE DAVID W Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2018-05-22 | POPS RICHARD F Director and CEO, Alkermes plc | Exercise or conversion | +20,000 | $12.29 | $246K | 686,352 |
| 2018-05-22 | POPS RICHARD F Director and CEO, Alkermes plc | Sale | −16,318 | $45.33 | $740K | 670,034 |
| 2018-05-22 | POPS RICHARD F Director and CEO, Alkermes plc | Sale | −3,682 | $46.03 | $169K | 666,352 |
| 2018-05-22 | POPS RICHARD F Director and CEO, Alkermes plc | Exercise or conversion · Employee Stock Option (Right to Buy) | −20,000 | 0 |
Page 89 of 90 · 1,796 trades